Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chen-Zhou Xu

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
World Journal of Gastrointestinal Oncology|July 29, 2024
Clinical benefits of transarterial chemoembolization combined with tyrosine kinase and immune checkpoint inhibitors for unresectable hepatocellular carcinomaFeng Han, Xiao-Han Wang, Chen-Zhou Xu
Combinatorial Chemistry & High Throughput Screening|January 12, 2024
Exploration of Key Genes Combining with Immune Infiltration Level andTumor Mutational Burden in Hepatocellular CarcinomaJing Chen, Lu Zhang, Cui-Hua Lu, et al.
Cancer Cell International|January 7, 2021
MCCC2 promotes HCC development by supporting leucine oncogenic functionYu-Yan Chen, Xue-Ning Zhang, Chen-Zhou Xu, et al.
Pathology, Research and Practice|April 3, 2019
High expression of Anxa2 and Stat3 promote progression of hepatocellular carcinoma and predict poor prognosisLei Tang, Jin-Xia Liu, Zi-Juan Zhang, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
World Journal of Gastrointestinal Oncology|July 29, 2024
Clinical benefits of transarterial chemoembolization combined with tyrosine kinase and immune checkpoint inhibitors for unresectable hepatocellular carcinomaFeng Han, Xiao-Han Wang, Chen-Zhou Xu
Combinatorial Chemistry & High Throughput Screening|January 12, 2024
Exploration of Key Genes Combining with Immune Infiltration Level andTumor Mutational Burden in Hepatocellular CarcinomaJing Chen, Lu Zhang, Cui-Hua Lu, et al.
Cancer Cell International|January 7, 2021
MCCC2 promotes HCC development by supporting leucine oncogenic functionYu-Yan Chen, Xue-Ning Zhang, Chen-Zhou Xu, et al.
Pathology, Research and Practice|April 3, 2019
High expression of Anxa2 and Stat3 promote progression of hepatocellular carcinoma and predict poor prognosisLei Tang, Jin-Xia Liu, Zi-Juan Zhang, et al.
Pageof 1